Amyloid oligomers exacerbate tau pathology in a mouse model of tauopathy

Selenica, Maj-Linda B., Brownlow, Milene, Jimenez, Jeffy P., Lee, Daniel C., Pena, Gabriela, Dickey, Chad A., Gordon, Marcia N., Morgan, Dave·2013·Neurodegenerative Diseases

Cited by (1,606)

Items 201–300 of 1,606

  1. β-Amyloid peptides enhance α-synuclein accumulation and neuronal deficits in a transgenic mouse model linking Alzheimer's disease and Parkinson's disease
    Masliah, Eliezer, Rockenstein, Edward, Veinbergs, Isaac, Sagara, Yutaka, Mallory, Margaret, Hashimoto, Makoto, Mucke, Lennart · 2001 · Proceedings of the National Academy of Sciences
  2. ScaleS: an optical clearing palette for biological imaging
    Hiroshi Hama, Hiroyuki Hioki, Kana Namiki, Tetsushi Hoshida, Hiroshi Kurokawa, Fumiyoshi Ishidate, Takeshi Kaneko, Takumi Akagi, Takashi Saito, Takaomi C. Saido et al. · 2015 · Nature Neuroscience
  3. Brain-Derived Neurotrophic Factor in Alzheimer’s Disease and Its Pharmaceutical Potential
    Gao, Lina, Zhang, Yun, Sterling, Keenan, Song, Weihong · 2022 · Translational Neurodegeneration
  4. Imaging the evolution and pathophysiology of Alzheimer disease
    Jagust, William · 2018 · Nature Reviews Neuroscience
  5. Levetiracetam suppresses neuronal network dysfunction and reverses synaptic and cognitive deficits in an Alzheimer’s disease model
    Sanchez, Pascal E., Zhu, Lei, Verret, Laure, Vossel, Keith A., Orr, Anna G., Cirrito, John R., Devidze, Nino, Ho, Kaitlyn, Yu, Gui-Qiu, Palop, Jorge J. et al. · 2012 · Proceedings of the National Academy of Sciences
  6. The Alzheimer's Disease Neuroimaging Initiative: Progress report and future plans
    Michael Walter Weiner, Paul S. S Aisen, Clifford R. Jack, William J. Jagust, John Q. Trojanowski, Leslie M. J. Shaw, Andrew J. Saykin, John C. Morris, Nigel J. Cairns, Laurel A. Beckett et al. · 2010 · Alzheimer s & Dementia
  7. Memory retrieval by activating engram cells in mouse models of early Alzheimer’s disease
    Dheeraj S. Roy, Autumn L. Arons, Teryn I. Mitchell, Michele Pignatelli, Tomás J. Ryan, Susumu Tonegawa · 2016 · Nature
  8. Basic mechanisms of neurodegeneration: a critical update
    K. A. Jellinger · 2010 · Journal of Cellular and Molecular Medicine
  9. Cellular and Molecular Mechanisms of Glial Scarring and Progressive Cavitation:In VivoandIn VitroAnalysis of Inflammation-Induced Secondary Injury after CNS Trauma
    Michael T. Fitch, Catherine M. Doller, Colin Kelly Combs, Gary E. Landreth, Jerry Silver · 1999 · Journal of Neuroscience
  10. Human amyloid-β synthesis and clearance rates as measured in cerebrospinal fluid in vivo
    Bateman, Randall J, Munsell, Ling Y, Morris, John C, Swarm, Robert, Yarasheski, Kevin E, Holtzman, David M · 2006 · Nature Medicine
  11. A multi-omic atlas of the human frontal cortex for aging and Alzheimer’s disease research
    De Jager, Philip L., Ma, Yiyi, McCabe, Cristin, Xu, Jishu, Vardarajan, Badri N., Felsky, Daniel, Klein, Hans-Ulrich, White, Charles C., Peters, Mette A., Lodgson, Ben et al. · 2018 · Scientific Data
  12. A new fate mapping system reveals context-dependent random or clonal expansion of microglia
    Tay, Tuan Leng, Mai, Dominic, Dautzenberg, Jana, Fernández-Klett, Francisco, Lin, Gen, Sagar, Datta, Moumita, Drougard, Anne, Stempfl, Thomas, Ardura-Fabregat, Alberto et al. · 2017 · Nature Neuroscience
  13. Astrocyte-Microglia Cross Talk through Complement Activation Modulates Amyloid Pathology in Mouse Models of Alzheimer's Disease
    Lian, Hong, Litvinchuk, Alexandra, Chiang, Angie C.-A., Aithmitti, Nadia, Jankowsky, Joanna L., Zheng, Hui · 2016 · The Journal of Neuroscience
  14. Altered Ribostasis: RNA-Protein Granules in Degenerative Disorders
    Mani Ramaswami, J. Paul Taylor, Roy Parker · 2013 · Cell
  15. Tau protein aggregation is associated with cellular senescence in the brain
    Musi, Nicolas, Valentine, Joseph M., Sickora, Kathryn R., Baeuerle, Eric, Thompson, Cody S., Shen, Qiang, Orr, Miranda E. · 2018 · Aging Cell
  16. Interplay between innate immunity and Alzheimer disease: APOE and TREM2 in the spotlight
    Shi, Yang, Holtzman, David M. · 2018 · Nature Reviews Immunology
  17. Neuroinflammation in Alzheimer disease
    Heneka, Michael T., van der Flier, Wiesje M., Jessen, Frank, Hoozemanns, Jeroen, Thal, Dietmar Rudolf, Boche, Delphine, Brosseron, Frederic, Teunissen, Charlotte, Zetterberg, Henrik, Jacobs, Andreas H. et al. · 2025 · Nature Reviews Immunology
  18. Functional Alterations in Memory Networks in Early Alzheimer’s Disease
    Reisa Anne Sperling, Bradford Clark Dickerson, Maija M. Pihlajamaki, Patrizia Vannini, Peter S. LaViolette, Ottavio V. Vitolo, Trey Hedden, John Alex Becker, Dorene M. Rentz, Dennis J. Selkoe et al. · 2010 · NeuroMolecular Medicine
  19. Complement C3 deficiency protects against neurodegeneration in aged plaque-rich APP/PS1 mice
    Shi, Qiaoqiao, Chowdhury, Saba, Ma, Rong, Le, Kevin X., Hong, Soyon, Caldarone, Barbara J., Stevens, Beth, Lemere, Cynthia A. · 2017 · Science Translational Medicine
  20. Impaired mitochondrial biogenesis, defective axonal transport of mitochondria, abnormal mitochondrial dynamics and synaptic degeneration in a mouse model of Alzheimer's disease
    Calkins, M. J., Manczak, M., Mao, P., Shirendeb, U., Reddy, P. H. · 2011 · Human Molecular Genetics
  21. Epileptic activity in Alzheimer’s disease: Causes and clinical relevance
    Vossel, Keith A, Tartaglia, Maria C, Nygaard, Haakon B, Zeman, Adam Z, Miller, Bruce L · 2017 · The Lancet Neurology
  22. RETRACTED ARTICLE: Pericyte loss influences Alzheimer-like neurodegeneration in mice
    Sagare, Abhay P., Bell, Robert D., Zhao, Zhen, Ma, Qingyi, Winkler, Ethan A., Ramanathan, Anita, Zlokovic, Berislav V. · 2013 · Nature Communications · Retracted
  23. Traumatic brain injury and amyloid-β pathology: a link to Alzheimer's disease?
    Johnson, Victoria E., Stewart, William, Smith, Douglas H. · 2010 · Nature Reviews Neuroscience
  24. Amyloid-β-independent regulators of tau pathology in Alzheimer disease
    van der Kant, Rik, Goldstein, Lawrence S. B., Ossenkoppele, Rik · 2020 · Nature reviews. Neuroscience
  25. Oligomeric Aβ-induced synaptic dysfunction in Alzheimer’s disease
    Shichun Tu, Shu‐ichi Okamoto, Stuart A. Lipton, Huaxi Xu · 2014 · Molecular Neurodegeneration
  26. Animal models of neurodegenerative diseases
    Dawson, Ted M., Golde, Todd E., Lagier-Tourenne, Clotilde · 2018 · Nature Neuroscience
  27. Uses for JNK: the Many and Varied Substrates of the c-Jun N-Terminal Kinases
    Marie A. Bogoyevitch, Boštjan Kobe · 2006 · Microbiology and Molecular Biology Reviews
  28. Methylomic profiling implicates cortical deregulation of ANK1 in Alzheimer's disease
    Lunnon, Katie, Smith, Rebecca, Hannon, Eilis, De Jager, Philip L, Srivastava, Gyan, Volta, Manuela, Troakes, Claire, Al-Sarraj, Safa, Burrage, Joe, Macdonald, Ruby et al. · 2014 · Nature Neuroscience
  29. Bidirectional relationship between sleep and Alzheimer’s disease: role of amyloid, tau, and other factors
    Chanung Wang, David M. Holtzman · 2019 · Neuropsychopharmacology
  30. Autosomal-dominant Alzheimer's disease: a review and proposal for the prevention of Alzheimer's disease
    Bateman, Randall J, Aisen, Paul S, De Strooper, Bart, Fox, Nick C, Lemere, Cynthia A, Ringman, John M, Salloway, Stephen, Sperling, Reisa A, Windisch, Manfred, Xiong, Chengjie · 2010 · Alzheimer's Research & Therapy
  31. Drug treatments in Alzheimer’s disease
    Briggs, Robert, Kennelly, Sean P, O’Neill, Desmond · 2016 · Clinical Medicine
  32. In Situ Imaging of Metals in Cells and Tissues
    Reagan L. McRae, Pritha Bagchi, S. Sumalekshmy, Christoph J. Fahrni · 2009 · Chemical Reviews
  33. Medial temporal lobe function and structure in mild cognitive impairment
    Bradford Clark Dickerson, David H. Salat, Julianna F. Bates, Monika Atiya, Ronald Killiany, Douglas N. Greve, Anders Martin Dale, Chantal E. Stern, Deborah Blacker, Marilyn Albert et al. · 2004 · Annals of Neurology
  34. Peripherally Applied Aβ-Containing Inoculates Induce Cerebral β-Amyloidosis
    Eisele, Yvonne S., Obermüller, Ulrike, Heilbronner, Götz, Baumann, Frank, Kaeser, Stephan A., Wolburg, Hartwig, Walker, Lary C., Staufenbiel, Matthias, Heikenwalder, Mathias, Jucker, Mathias · 2010 · Science
  35. Neuropathology and Pathogenesis of Encephalitis following Amyloid β Immunization in Alzheimer's Disease
    Isidró Ferrer, Merçé Boada, María Luisa Sánchez Guerra, Maria Jesus Rey, F. R. Costa‐Jussà · 2004 · Brain Pathology
  36. The road to restoring neural circuits for the treatment of Alzheimer's disease
    Canter, Rebecca G., Penney, Jay, Tsai, Li-Huei · 2016 · Nature
  37. Aβ42 Is Essential for Parenchymal and Vascular Amyloid Deposition in Mice
    McGowan, Eileen, Pickford, Fiona, Kim, Jungsu, Onstead, Luisa, Eriksen, Jason, Yu, Cindy, Skipper, Lisa, Murphy, M. Paul, Beard, Jenny, Das, Pritam et al. · 2005 · Neuron
  38. Therapeutics for Alzheimer's Disease Based on the Metal Hypothesis
    Ashley Ian Bush, Rudolph E. Tanzi · 2008 · Neurotherapeutics
  39. The Alzheimer’s Disease Mitochondrial Cascade Hypothesis
    Swerdlow, Russell H., Burns, Jeffrey M., Khan, Shaharyar M. · 2010 · Journal of Alzheimer s Disease
  40. Molecular drivers and cortical spread of lateral entorhinal cortex dysfunction in preclinical Alzheimer's disease
    Khan, Usman A, Liu, Li, Provenzano, Frank A, Berman, Diego E, Profaci, Caterina P, Sloan, Richard, Mayeux, Richard, Duff, Karen E, Small, Scott A · 2014 · Nature Neuroscience
  41. A brief history of organoids
    Corrò, Claudia, Novellasdemunt, Laura, Li, Vivian S.W. · 2020 · American Journal of Physiology-Cell Physiology
  42. Large-scale deep multi-layer analysis of Alzheimer’s disease brain reveals strong proteomic disease-related changes not observed at the RNA level
    Johnson, Erik C. B., Carter, E. Kathleen, Dammer, Eric B., Duong, Duc M., Gerasimov, Ekaterina S., Liu, Yue, Liu, Jiaqi, Betarbet, Ranjita, Ping, Lingyan, Yin, Luming et al. · 2022 · Nature Neuroscience
  43. Microglia contribute to normal myelinogenesis and to oligodendrocyte progenitor maintenance during adulthood
    Hagemeyer, Nora, Hanft, Klara-Maria, Akriditou, Maria-Anna, Unger, Nicole, Park, Eun S., Stanley, E. Richard, Staszewski, Ori, Dimou, Leda, Prinz, Marco · 2017 · Acta Neuropathologica
  44. Incidence and impact of subclinical epileptiform activity in Alzheimer’s disease.
    Vossel, Keith A., Ranasinghe, Kamalini G., Beagle, Alexander J., Mizuiri, Danielle, Honma, Susanne M., Dowling, Anne F., Darwish, Sonja M., Van Berlo, Victoria, Barnes, Deborah E., Mantle, Mary et al. · 2016 · Annals of Neurology
  45. Microglial cell dysregulation in brain aging and neurodegeneration
    von Bernhardi, Rommy, Eugenín-von Bernhardi, Laura, Eugenín, Jaime · 2015 · Frontiers in Aging Neuroscience
  46. On the path to 2025: understanding the Alzheimer’s disease continuum
    Aisen, Paul S., Cummings, Jeffrey, Jack, Clifford R., Morris, John C., Sperling, Reisa, Frölich, Lutz, Jones, Roy W., Dowsett, Sherie A., Matthews, Brandy R., Raskin, Joel et al. · 2017 · Alzheimer's Research & Therapy
  47. Dual Functions of Microglia in Ischemic Stroke
    Chuan Qin, Luo‐Qi Zhou, Xiao-Tong Ma, Zi-Wei Hu, Sheng Yang, Man Chen, Dale B. Bosco, Long‐Jun Wu, Dai‐Shi Tian · 2019 · Neuroscience Bulletin
  48. Dendritic Spine Abnormalities in Amyloid Precursor Protein Transgenic Mice Demonstrated by Gene Transfer and Intravital Multiphoton Microscopy
    Spires, Tara L., Meyer-Luehmann, Melanie, Stern, Edward A., McLean, Pamela J., Skoch, Jesse, Nguyen, Paul T., Bacskai, Brian J., Hyman, Bradley T. · 2005 · The Journal of Neuroscience
  49. Take five—BACE and the γ‐secretase quartet conduct Alzheimer's amyloid β‐peptide generation
    Christian Haass · 2004 · The EMBO Journal
  50. Solid-State NMR Studies of Amyloid Fibril Structure
    Robert Tycko · 2011 · Annual Review of Physical Chemistry
  51. Clearance of Amyloid-β Peptide Across the Blood-Brain Barrier: Implication for Therapies in Alzheimers Disease
    Rashid Deane, Robert D. Bell, Abhay P. Sagare, Berislav V. Zloković · 2009 · CNS & Neurological Disorders - Drug Targets
  52. Linking Aβ and Tau in Late-Onset Alzheimer's Disease: A Dual Pathway Hypothesis
    Small, Scott A., Duff, Karen · 2008 · Neuron
  53. Synapse Formation and Function Is Modulated by the Amyloid Precursor Protein
    Christina Priller, Thomas Bauer, Gerda Mitteregger, Bjarne Krebs, Hans A. Kretzschmar, Jochen Wolfgang Herms · 2006 · Journal of Neuroscience
  54. Mitochondrial dysfunction and oxidative stress in aging and cancer
    Anna V. Kudryavtseva, George Sergeevich Krasnov, Alexey Alexandrovich Dmitriev, B. Yа. Alekseev, Olga L. Kardymon, А. Ф. Садритдинова, Maria Fedorova, Anatoly V. Pokrovsky, Nataliya V. Melnikova, А. Д. Каприн et al. · 2016 · Oncotarget
  55. Caspase-cleavage of tau is an early event in Alzheimer disease tangle pathology
    Rissman, Robert A., Poon, Wayne W., Blurton-Jones, Mathew, Oddo, Salvatore, Torp, Reidun, Vitek, Michael P., LaFerla, Frank M., Rohn, Troy T., Cotman, Carl W. · 2004 · Journal of Clinical Investigation
  56. The paradoxical pro- and anti-apoptotic actions of GSK3 in the intrinsic and extrinsic apoptosis signaling pathways
    Eléonore Beurel, Richard Scott Jope · 2006 · Progress in Neurobiology
  57. Biochemistry of Amyloid -Protein and Amyloid Deposits in Alzheimer Disease
    Colin Louis Masters, Dennis J. Selkoe · 2012 · Cold Spring Harbor Perspectives in Medicine
  58. Brain imaging and fluid biomarker analysis in young adults at genetic risk for autosomal dominant Alzheimer's disease in the presenilin 1 E280A kindred: a case-control study
    Reiman, Eric M, Quiroz, Yakeel T, Fleisher, Adam S, Chen, Kewei, Velez-Pardo, Carlos, Jimenez-Del-Rio, Marlene, Fagan, Anne M, Shah, Aarti R, Alvarez, Sergio, Arbelaez, Andrés et al. · 2012 · The Lancet Neurology
  59. Neuroprotection by adenosine in the brain: From A1 receptor activation to A2A receptor blockade
    Rodrigo Antunes Cunha · 2005 · Purinergic Signalling
  60. Curcumin and its Derivatives: Their Application in Neuropharmacology and Neuroscience in the 21st Century
    Wing‐Hin Lee, Ching‐Yee Loo, Mary Bebawy, Frederick Luk, Rebecca Sara Mason, Ramin Rohanizadeh · 2013 · Current Neuropharmacology
  61. Amyloid-Beta: A Crucial Factor in Alzheimer's Disease
    Saeed Sadigh‐Eteghad, Babak Sabermarouf, Alireza Majdi, Mahnaz Talebi, Mehdi Farhoudi, Javad Mahmoudi · 2014 · Medical Principles and Practice
  62. The Role of NMDA Receptors in Alzheimer’s Disease
    Liu, Jinping, Chang, Lirong, Song, Yizhi, Li, Hui, Wu, Yan · 2019 · Frontiers in Neuroscience
  63. A Transgenic Alzheimer Rat with Plaques, Tau Pathology, Behavioral Impairment, Oligomeric Aβ, and Frank Neuronal Loss
    Robert M. Cohen, Kavon P. Rezai-Zadeh, Tara M. Weitz, Altan Rentsendorj, David Gate, Inna E Spivak, Yasmin Bholat, Vitaly Vasilevko, Charles G. Glabe, Joshua J. Breunig et al. · 2013 · Journal of Neuroscience
  64. Pharmacological targeting of CSF1R inhibits microglial proliferation and prevents the progression of Alzheimer’s-like pathology
    Olmos-Alonso, Adrian, Schetters, Sjoerd T. T., Sri, Sarmi, Askew, Katharine, Mancuso, Renzo, Vargas-Caballero, Mariana, Holscher, Christian, Perry, V. Hugh, Gomez-Nicola, Diego · 2016 · Brain
  65. The significance of the cholinergic system in the brain during aging and in Alzheimer’s disease
    Reinhard Schliebs, Thomas Arendt · 2006 · Journal of Neural Transmission
  66. Inflammation: the link between comorbidities, genetics, and Alzheimer’s disease
    Newcombe, Estella A., Camats-Perna, Judith, Silva, Mallone L., Valmas, Nicholas, Huat, Tee Jong, Medeiros, Rodrigo · 2018 · Journal of Neuroinflammation
  67. Lipopolysaccharide-induced neuroinflammation as a bridge to understand neurodegeneration
    Batista, Carla Ribeiro Alvares, Gomes, Giovanni Freitas, Candelario-Jalil, Eduardo, Fiebich, Bernd L., de Oliveira, Antonio Carlos Pinheiro · 2019 · International Journal of Molecular Sciences
  68. Fluorescent small organic probes for biosensing
    Xue Tian, Lloyd C. Murfin, Luling Wu, Simon E. Lewis, Tony D. James · 2021 · Chemical Science
  69. Mechanisms of Aβ Clearance and Degradation by Glial Cells
    Ries, Miriam, Sastre, Magdalena · 2016 · Frontiers in Aging Neuroscience
  70. Amyloid <i>β</i> -Peptide (1–42)-Induced Oxidative Stress in Alzheimer Disease: Importance in Disease Pathogenesis and Progression
    Butterfield, D. Allan, Swomley, Aaron M., Sultana, Rukhsana · 2013 · Antioxidants &amp; Redox Signaling
  71. Tau stabilizes microtubules by binding at the interface between tubulin heterodimers
    Kadavath, Harindranath, Hofele, Romina V., Biernat, Jacek, Kumar, Satish, Tepper, Katharina, Urlaub, Henning, Mandelkow, Eckhard, Zweckstetter, Markus · 2015 · Proceedings of the National Academy of Sciences
  72. Microglia during development and aging
    Harry, G. Jean · 2013 · Pharmacology &amp; Therapeutics
  73. Distinct clinical and pathological characteristics of frontotemporal dementia associated with C9ORF72 mutations
    Snowden, J. S., Rollinson, S., Thompson, J. C., Harris, J. M., Stopford, C. L., Richardson, A. M. T., Jones, M., Gerhard, A., Davidson, Y. S., Robinson, A. et al. · 2012 · Brain
  74. Inconsistencies and Controversies Surrounding the Amyloid Hypothesis of Alzheimer's Disease
    Morris, Gary P, Clark, Ian A, Vissel, Bryce · 2014 · Acta Neuropathologica Communications
  75. BACE1, a Major Determinant of Selective Vulnerability of the Brain to Amyloid-β Amyloidogenesis, is Essential for Cognitive, Emotional, and Synaptic Functions
    Laird, Fiona M., Cai, Huaibin, Savonenko, Alena V., Farah, Mohamed H., He, Kaiwen, Melnikova, Tatyana, Wen, Hongjin, Chiang, Hsueh-Cheng, Xu, Guilian, Koliatsos, Vassilis E. et al. · 2005 · The Journal of Neuroscience
  76. Tau promotes neurodegeneration through global chromatin relaxation
    Frost, Bess, Hemberg, Martin, Lewis, Jada, Feany, Mel B · 2014 · Nature Neuroscience
  77. Missense and silent tau gene mutations cause frontotemporal dementia with parkinsonism-chromosome 17 type, by affecting multiple alternative RNA splicing regulatory elements.
    I. D'Souza, P. Poorkaj, Ming Hong, D. Nochlin, V. Lee, T. Bird, G. Schellenberg · 1999 · Proceedings of the National Academy of Sciences of the United States of America
  78. Environmental Enrichment Mitigates Cognitive Deficits in a Mouse Model of Alzheimer's Disease
    Jankowsky, Joanna L., Melnikova, Tatiana, Fadale, Daniel J., Xu, Guilian M., Slunt, Hilda H., Gonzales, Victoria, Younkin, Linda H., Younkin, Steven G., Borchelt, David R., Savonenko, Alena V. · 2005 · The Journal of Neuroscience
  79. Tau and neuroinflammation in Alzheimer’s disease: interplay mechanisms and clinical translation
    Chen, Yijun, Yu, Yang · 2023 · Journal of Neuroinflammation
  80. Critical role of acetylation in tau-mediated neurodegeneration and cognitive deficits
    Min, Sang-Won, Chen, Xu, Tracy, Tara E, Li, Yaqiao, Zhou, Yungui, Wang, Chao, Shirakawa, Kotaro, Minami, S Sakura, Defensor, Erwin, Mok, Sue Ann et al. · 2015 · Nature Medicine
  81. The Indispensable Roles of Microglia and Astrocytes during Brain Development
    Reemst, Kitty, Noctor, Stephen C., Lucassen, Paul J., Hol, Elly M. · 2016 · Frontiers in Human Neuroscience
  82. Tau reduction prevents neuronal loss and reverses pathological tau deposition and seeding in mice with tauopathy
    DeVos, Sarah L., Miller, Rebecca L., Schoch, Kathleen M., Holmes, Brandon B., Kebodeaux, Carey S., Wegener, Amy J., Chen, Guo, Shen, Tao, Tran, Hien, Nichols, Brandon et al. · 2017 · Science Translational Medicine
  83. Neuroprotective effects of curcumin
    Cole, Greg M., Teter, Bruce, Frautschy, Sally A. · 2007 · ADVANCES IN EXPERIMENTAL MEDICINE AND BIOLOGY
  84. The probabilistic model of Alzheimer disease: the amyloid hypothesis revised
    Frisoni, Giovanni B., Altomare, Daniele, Thal, Dietmar Rudolf, Ribaldi, Federica, van der Kant, Rik, Ossenkoppele, Rik, Blennow, Kaj, Cummings, Jeffrey, van Duijn, Cornelia, Nilsson, Peter M. et al. · 2022 · Nature Reviews Neuroscience
  85. The activities of amyloids from a structural perspective
    Roland Riek, David S Eisenberg · 2016 · Nature
  86. Cell-cycle reentry and cell death in transgenic mice expressing nonmutant human tau isoforms
    Andorfer, Cathy, Acker, Christopher M., Kress, Yvonne, Hof, Patrick R., Duff, Karen, Davies, Peter · 2005 · The Journal of Neuroscience
  87. Resting state functional connectivity in preclinical Alzheimer’s disease
    Sheline, Yvette I., Raichle, Marcus E. · 2013 · Biological Psychiatry
  88. Phosphorylated Tau in Alzheimer’s Disease and Other Tauopathies
    Rawat, Priyanka, Sehar, Ujala, Bisht, Jasbir, Selman, Ashley, Culberson, John, Reddy, P. Hemachandra · 2022 · International Journal of Molecular Sciences
  89. Immunotherapy Targeting Pathological Tau Conformers in a Tangle Mouse Model Reduces Brain Pathology with Associated Functional Improvements
    Asuni, Ayodeji A., Boutajangout, Allal, Quartermain, David, Sigurdsson, Einar M. · 2007 · The Journal of Neuroscience
  90. Diabetes-accelerated memory dysfunction via cerebrovascular inflammation and Aβ deposition in an Alzheimer mouse model with diabetes
    Shuko Takeda, Naoyuki Sato, Kozue Uchio‐Yamada, Kyoko Sawada, Takanori Kunieda, Daisuke Takeuchi, Hitomi Kurinami, Mitsuru Shinohara, Hiromi Rakugi, Ryuichi Morishita · 2010 · Proceedings of the National Academy of Sciences
  91. Colony-stimulating factor 1 receptor inhibition prevents microglial plaque association and improves cognition in 3xTg-AD mice
    Dagher, Nabil N., Najafi, Allison R., Kayala, Kara M. Neely, Elmore, Monica R. P., White, Terra E., Medeiros, Rodrigo, West, Brian L., Green, Kim N. · 2015 · Journal of Neuroinflammation
  92. Mechanism of Oxidative Stress and Synapse Dysfunction in the Pathogenesis of Alzheimer’s Disease: Understanding the Therapeutics Strategies
    Pradip Kumar Kamat, Anuradha Kalani, Shivika Rai, Supriya Swarnkar, Santoshkumar Tota, Chandishwar Nath, Neetu Tyagi · 2014 · Molecular Neurobiology
  93. Frontotemporal Lobar Degeneration
    Gil Dan Rabinovici, Bruce L. Miller · 2010 · CNS Drugs
  94. Sleep, Cognition, and Normal Aging
    Michael K. Scullin, Donald L. Bliwise · 2015 · Perspectives on Psychological Science
  95. Heparin-induced tau filaments are polymorphic and differ from those in Alzheimer’s and Pick’s diseases
    Wenjuan Zhang, Benjamin Falcon, Alexey G. Murzin, Juan Fan, R. Anthony Crowther, Michel Goedert, Sjors H. W. Scheres · 2019 · eLife
  96. Inflammation and Oxidative Stress: The Molecular Connectivity between Insulin Resistance, Obesity, and Alzheimer’s Disease
    Giuseppe Verdile, Kevin Noel Keane, Vínicius Fernandes Cruzat, Sandra Medic, Miheer Sabale, Joanne Rowles, Nadeeja Wijesekara, Ralph Nigel Martins, Paul E. Fraser, Philip Newsholme · 2015 · Mediators of Inflammation
  97. Toll-like receptors in health and disease in the brain: mechanisms and therapeutic potential
    Mark L. Hanke, Tammy Kielian · 2011 · Clinical Science
  98. Different Conformations of Amyloid β Induce Neurotoxicity by Distinct Mechanisms in Human Cortical Neurons
    Atul M. Deshpande, Erene W. Mina, Charles G. Glabe, Jorge A. Busciglio · 2006 · Journal of Neuroscience
  99. Neuroinflammation after Intracerebral Hemorrhage and Potential Therapeutic Targets
    Christine Tschoe, Cheryl Bushnell, Pamela Woods Duncan, Martha A. Alexander‐Miller, Stacey Q Wolfe · 2020 · Journal of Stroke
  100. Single-cell atlas reveals correlates of high cognitive function, dementia, and resilience to Alzheimer’s disease pathology
    Mathys, Hansruedi, Peng, Zhuyu, Boix, Carles A., Victor, Matheus B., Leary, Noelle, Babu, Sudhagar, Abdelhady, Ghada, Jiang, Xueqiao, Ng, Ayesha P., Ghafari, Kimia et al. · 2023 · Cell